Rudolf Schroeder

Title: Rudolf Schroeder: A Pioneer in Pharmaceutical Innovations

Introduction

Rudolf Schroeder, a distinguished inventor based in Worms-Pfeddersheim, Germany, has contributed significantly to the field of pharmaceuticals with his innovative inventions. With two patents to his name, his work embodies a commitment to advancing drug formulation technologies.

Latest Patents

Schroeder's latest patents focus on solid compositions that feature Compound I, or its pharmaceutically acceptable salts. The first patent details solid compositions comprising these compounds in an amorphous form, emphasizing the formulation in an amorphous solid dispersion that includes a pharmaceutically acceptable hydrophilic polymer and surfactant. The second patent similarly showcases solid compositions characterized by the amorphous state of Compound I, highlighting the advantages of this formulation approach for improved pharmaceutical applications.

Career Highlights

Throughout his career, Rudolf Schroeder has been associated with prominent companies in the pharmaceutical sector, including AbbVie Inc. and AbbVie Ireland Unlimited Company. His experience at these organizations has allowed him to develop and refine his expertise in drug formulation and pharmaceutical innovations, leading to his significant contributions in the field.

Collaborations

In his professional journey, Schroeder has collaborated with esteemed colleagues such as Yi Gao and Jianwei Wu. These collaborations have enhanced his research endeavors, fostering an environment of creativity and innovation in the development of new pharmaceutical formulations.

Conclusion

Rudolf Schroeder stands out as an influential inventor whose patents have the potential to advance the pharmaceutical industry. His work on solid compositions reflects a deep understanding of drug formulation, and his contributions are likely to pave the way for future innovations in the field.